- Lobbying
- Lobbying by Hepatitis B Foundation
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
MIKE HALL | n/a |
Alyson Lewis | n/a |
J. Michael Hall | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Disease Control & Prevention (CDC)
Natl Institutes of Health (NIH)
Type of Issue
Termination
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Disease Control & Prevention (CDC)
Natl Institutes of Health (NIH)
Type of Issue
Amendment
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Disease Control & Prevention (CDC)
Natl Institutes of Health (NIH)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Disease Control & Prevention (CDC)
Natl Institutes of Health (NIH)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Disease Control & Prevention (CDC)
Natl Institutes of Health (NIH)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Disease Control & Prevention (CDC)
Natl Institutes of Health (NIH)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Disease Control & Prevention (CDC)
Natl Institutes of Health (NIH)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Disease Control & Prevention (CDC)
Natl Institutes of Health (NIH)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Disease Control & Prevention (CDC)
Natl Institutes of Health (NIH)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Disease Control & Prevention (CDC)
Natl Institutes of Health (NIH)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Disease Control & Prevention (CDC)
Natl Institutes of Health (NIH)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Disease Control & Prevention (CDC)
Natl Institutes of Health (NIH)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Disease Control & Prevention (CDC)
Natl Institutes of Health (NIH)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Disease Control & Prevention (CDC)
Natl Institutes of Health (NIH)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Disease Control & Prevention (CDC)
Natl Institutes of Health (NIH)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Disease Control & Prevention (CDC)
Natl Institutes of Health (NIH)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Disease Control & Prevention (CDC)
Natl Institutes of Health (NIH)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Disease Control & Prevention (CDC)
Natl Institutes of Health (NIH)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Disease Control & Prevention (CDC)
Natl Institutes of Health (NIH)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Disease Control & Prevention (CDC)
Natl Institutes of Health (NIH)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Disease Control & Prevention (CDC)
Natl Institutes of Health (NIH)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Disease Control & Prevention (CDC)
Natl Institutes of Health (NIH)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Disease Control & Prevention (CDC)
Natl Institutes of Health (NIH)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Disease Control & Prevention (CDC)
Natl Institutes of Health (NIH)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Disease Control & Prevention (CDC)
Natl Institutes of Health (NIH)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Disease Control & Prevention (CDC)
Natl Institutes of Health (NIH)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Disease Control & Prevention (CDC)
Natl Institutes of Health (NIH)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Disease Control & Prevention (CDC)
Natl Institutes of Health (NIH)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Centers For Disease Control & Prevention (CDC)
Defense Threat Reduction Agency (DTRA)
Natl Institutes of Health (NIH)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Centers For Disease Control & Prevention (CDC)
Defense Threat Reduction Agency (DTRA)
Natl Institutes of Health (NIH)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Centers For Disease Control & Prevention (CDC)
Defense Threat Reduction Agency (DTRA)
Natl Institutes of Health (NIH)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Centers For Disease Control & Prevention (CDC)
Defense Threat Reduction Agency (DTRA)
Natl Institutes of Health (NIH)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Centers For Disease Control & Prevention (CDC)
Defense Threat Reduction Agency (DTRA)
Natl Institutes of Health (NIH)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Centers For Disease Control & Prevention (CDC)
Defense Threat Reduction Agency (DTRA)
Natl Institutes of Health (NIH)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Centers For Disease Control & Prevention (CDC)
Defense Threat Reduction Agency (DTRA)
Natl Institutes of Health (NIH)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Centers For Disease Control & Prevention (CDC)
Defense Threat Reduction Agency (DTRA)
Natl Institutes of Health (NIH)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Centers For Disease Control & Prevention (CDC)
Defense Threat Reduction Agency (DTRA)
Natl Institutes of Health (NIH)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Centers For Disease Control & Prevention (CDC)
Defense Threat Reduction Agency (DTRA)
Natl Institutes of Health (NIH)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Centers For Disease Control & Prevention (CDC)
Defense Threat Reduction Agency (DTRA)
Natl Institutes of Health (NIH)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Centers For Disease Control & Prevention (CDC)
Defense Threat Reduction Agency (DTRA)
Natl Institutes of Health (NIH)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Centers For Disease Control & Prevention (CDC)
Defense Threat Reduction Agency (DTRA)
Natl Institutes of Health (NIH)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Centers For Disease Control & Prevention (CDC)
Defense Threat Reduction Agency (DTRA)
Natl Institutes of Health (NIH)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Centers For Disease Control & Prevention (CDC)
Defense Threat Reduction Agency (DTRA)
Natl Institutes of Health (NIH)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Centers For Disease Control & Prevention (CDC)
Defense Threat Reduction Agency (DTRA)
Natl Institutes of Health (NIH)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Centers For Disease Control & Prevention (CDC)
Defense Threat Reduction Agency (DTRA)
Natl Institutes of Health (NIH)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Centers For Disease Control & Prevention (CDC)
Defense Threat Reduction Agency (DTRA)
Natl Institutes of Health (NIH)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Centers For Disease Control & Prevention (CDC)
Defense Threat Reduction Agency (DTRA)
Natl Institutes of Health (NIH)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Centers For Disease Control & Prevention (CDC)
Defense Threat Reduction Agency (DTRA)
Natl Institutes of Health (NIH)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Centers For Disease Control & Prevention (CDC)
Defense Threat Reduction Agency (DTRA)
Natl Institutes of Health (NIH)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Centers For Disease Control & Prevention (CDC)
Defense Threat Reduction Agency (DTRA)
Natl Institutes of Health (NIH)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Centers For Disease Control & Prevention (CDC)
Defense Threat Reduction Agency (DTRA)
Natl Institutes of Health (NIH)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Defense Threat Reduction Agency (DTRA)
Centers For Disease Control & Prevention (CDC)
Natl Institutes of Health (NIH)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Centers For Disease Control & Prevention (CDC)
Defense Threat Reduction Agency (DTRA)
Natl Institutes of Health (NIH)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Centers For Disease Control & Prevention (CDC)
Defense Threat Reduction Agency (DTRA)
Natl Institutes of Health (NIH)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Centers For Disease Control & Prevention (CDC)
Defense Threat Reduction Agency (DTRA)
Natl Institutes of Health (NIH)
Type of Issue
Health Issues
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Centers For Disease Control & Prevention (CDC)
Defense Threat Reduction Agency (DTRA)
Natl Institutes of Health (NIH)
Type of Issue
Health Issues
Registration
Issue(s) they said they’d lobby about: Budget and Appropriations in Support of Hepatitis B Foundation Interests.
MM Report
Lobbying Issues
Agencies Lobbied
DOD
Type of Issue
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate